In an independent publicly available database (GSE51373) encompassing both chemotherapy-sensitive (PFS > 18 months) and -resistant (PFS < 8 months) HGSOC patients, we observed significantly higher SUB1 expression in tumor samples of platinum-resistant HGSOC patients compared to sensitive ones (p < 0.01) (Fig. 8H). The gene discussed is SUB1; the disease is neoplasm.